News story from Gizmodo on Tuesday 04 May 2021
Gizmodo,
March-In Rights And Compulsory Licensing—Safety Nets For Access To A COVID-19 Vaccine
Health Affairs,
In 1955, journalist Edward R. Murrow asked Jonas Salk: Who owns the patent to the polio vaccine? He responded famously, “Well…
Single-Payer Drug Pricing In A Multipayer Health System: Does Germany Offer A Model For The US?
Health Affairs,
An increasing number of presidential hopefuls, most recently Senator Kamala Harris, are proposing “single payer” or “Medicare…
Drug Prices by Committee: One Way Biden Could Lower Costs
New York Times,
The New Health Care Many countries use independent review boards to balance innovation and profit.
Blame medication price gouging on spineless politicians
Newsbreak,
Thought Catalog/Unsplash An article published in Journal of the American Medical Association spells out just why prescription…
Balancing Lower U.S. Prescription Drug Prices And Innovation – Part 2
Health Affairs,
In Part 1 of this post, we provided background on U.S. drug prices and summarized an expert roundtable discussion held in June…
Balancing Lower U.S. Prescription Drug Prices And Innovation – Part 1
Health Affairs,
Most Americans believe U.S. prescription drug prices are too high—a conclusion reinforced by almost 3 in 10 Americans reporting…
Balancing lower U.S. prescription drug prices and innovation – Part 1
Brookings,
By Steven M. Lieberman, Paul Ginsburg, Kavita Patel Most Americans believe U.S.
Stop Paying Too Much For Your IPOs - Get GoodRx Today
Seeking Alpha,
Summary GoodRx has managed to marry technology with a lasting, polarizing and colossal issue impacting society - healthcare…
March-In Rights And Compulsory Licensing—Safety Nets For Access To A COVID-19 Vaccine
Health Affairs,
In 1955, journalist Edward R. Murrow asked Jonas Salk: Who owns the patent to the polio vaccine? He responded famously, “Well…
News story from Eurasia Review on Wednesday 25 March 2020
Eurasia Review,
The Decade of Transformation Is Here: Remaking Health Care
Globalresearch,
We’ve been writing for a while that the 2020’s would be a decade when multiple crises would come to a head and we would have an…
Fact check: Is Big Pharma’s take on the Pelosi drug-pricing bill fair warning or fearmongering?
Bozeman Daily Chronicle,
House Speaker Nancy Pelosi’s flagship proposal to curb prescription drug prices, the “Lower Drug Costs Now Act” — H.R.
Pharma’s take on the Pelosi drug-pricing bill: Fair warning or fearmongering?
The Medical News,
House Speaker Nancy Pelosi's flagship proposal to curb prescription drug prices, the "Lower Drug Costs Now Act" - H.R.
Pharma’s Take On The Pelosi Drug-Pricing Bill: Fair Warning Or Fearmongering?
Lancaster Online,
House Speaker Nancy Pelosi’s flagship proposal to curb prescription drug prices, the “Lower Drug Costs Now Act” ― H.R.
Pharma’s Take On The Pelosi Drug-Pricing Bill: Fair Warning Or Fearmongering?
The Record,
[khn—slabs slabs="1027675" view="inline" /] [partner-box]House Speaker Nancy Pelosi’s flagship proposal to curb prescription…
Pharma’s Take On The Pelosi Drug-Pricing Bill: Fair Warning Or Fearmongering?
Kaiser Health News,
“Speaker Pelosi’s drug pricing plan would siphon $1 trillion or more from biopharmaceutical innovators over the next 10 years.
House Commerce Committee Issues Hearing Memo on Making Prescription Drugs More Affordable
Insurance News Net,
Targeted News Service WASHINGTON, Sept. 18 -- The House Energy and Commerce Committee issued the following hearing memorandum…
Why a plan to lower prescription drug prices should not be piecemeal
MedicalXpress,
A man looks at a prescription drug bottle. Many Americans will chronic conditions report rationing their drugs because of cost.
Why a plan to lower prescription drug prices should not be piecemeal
Toronto Telegraph,
Demand for prescription medications in the U.S. is at an all time high, given that 50% of adults have at least one chronic…
News story from Big News Network on Tuesday 10 September 2019
Big News Network,
MIL-OSI Global: Why a plan to lower prescription drug prices should not be piecemeal
Foreign Affairs New Zealand,
Post sponsored by NewzEngine.com Source: The Conversation – USA – By Minal R. Patel, Associate Professor of Health Behavior
Why a plan to lower prescription drug prices should not be piecemeal
The Conversation,
Demand for prescription medications in the U.S. is at an all time high, given that 50% of adults have at least one chronic…
Why a plan to lower prescription drug prices should not be piecemeal
SFGate,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Minal R.
Why a plan to lower prescription drug prices should not be piecemeal
Idaho Press,
( is an independent and nonprofit source of news, analysis and commentary from academic experts.), and, (THE CONVERSATION…
Why a plan to lower prescription drug prices should not be piecemeal
Seattle Post-Intelligencer,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Minal R.
Why a plan to lower prescription drug prices should not be piecemeal
Lincoln Journal Star,
(THE CONVERSATION) Demand for prescription medications in the U.S. is at an all time high, given that 50% of adults have at…
Price of snakebite drug is sky high, likely to stay that way
Union Leader,
Dr. Steven Curry has treated patients with snakebites since the 1980s — long enough to remember when the treatment represented…
Price of snakebite drug is sky high, but new competitor unlikely to lower costs
The Medical News,
Dr. Steven Curry has treated patients with snakebites since the 1980s — long enough to remember when the treatment represented…
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WCBE ,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
KOSU,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
KTEP El Paso,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Radio Acadie,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Omaha Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Witchita's Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
KCLU,
Tais Policanti / Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites…
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Kansas City University Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
KRWG TV/FM,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
North East Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
KERA News,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
KUNM,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
SDPB Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Central Coast Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
New Hampshire Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Arizona Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
A Koahnic Broadcast Station,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Northeastern Indiana Public Radio ,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
New England Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WYPR,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WRKF,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Interlochen Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Price Of Snakebite Drug Is Sky High, But New Competitor Unlikely To Lower Costs
Fox News 26,
Dr. Steven Curry has treated patients with snakebites since the 1980s — long enough to remember when the treatment represented…
Price Of Snakebite Drug Is Sky High, But New Competitor Unlikely To Lower Costs
Kaiser Health News,
Dr. Steven Curry has treated patients with snakebites since the 1980s — long enough to remember when the treatment represented…
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
KPBS,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WVTF,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
The University of New Orleans Public Radio ,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WVPE,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WXPR,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WUKY,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Delmarva Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WKAR,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WUNC,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WUWM,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WLRN,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Tri States Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Northern Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WJCT,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WVXU,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Georgia Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Kansas Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Boise State Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Iowa Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Wyoming Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Der Überlebenswille ist eingepreist
ZEIT ONLINE,
Die Pharmabranche ist kaum reguliert, die Patienten haben kaum eine Wahl: Wer in den USA Medikamente braucht, verzweifelt oft…
Trump Plans New ‘Favored Nations Clause’ to Tie Drug Prices to the Cost Other...
Biospace,
Nicole S Glass / Shutterstock In his latest move to drive down the costs of prescription drugs in the United States, President…
U.S. Companies Continue to Pay More in Healthcare as the Cost of Drugs Keeps ...
Biospace,
The rising cost of healthcare has been a hot topic of discussion as of late throughout the United States, with many…
Pharmacist Involvement in Population Health Management for a Pediatric Managed Medicaid ...
Medical Health News,
Review Pharmacist Involvement in Population Health Management for a Pediatric Managed Medicaid Accountable Care Organization…
Opinion: Negotiating drug prices without restricting patient access: lessons from Germany
Yahoo! News,
In the ongoing conversation about high drug prices in the United States, some loud voices argue that the solution is to allow…
News story from Stat News on Thursday 27 June 2019
Stat News,
House Energy
Insurance News Net,
WASHINGTON, May 15 -- The House Energy and Commerce Committee issued a report (H.Rpt.
Uncertainty Clouds States' Plans to Import Prescription Drugs From Canada
Governing Magazine ,
Two states often on opposite sides of the political spectrum have landed on the same solution to rising drug prices: import…
Florida Wants to Import Canadian Drugs; Critics Fear Safety Risks
The Washington Free Beacon,
Amid ever-rising prescription drug costs, a bill working its way through the Florida state legislature is the latest effort to…
Half of the world's diabetics won't have insulin by 2030, study says
UPI.com,
Nov. 21 (UPI) -- By 2030, about half of the 79 million adults around the globe predicted to have type 2 diabetes won't have…
Amgen lowers cholesterol drug Repatha cost 60% amid political talk of high drug prices
CNN News,
Even with a coupon, if you were to fill the prescription for a single cartridge the average price was around $1,435 according…
Amgen lowers cholesterol drug Repatha cost 60% amid political talk of high drug prices
Action News Now,
The pharmaceutical company Amgen announced Wednesday that it will decrease the price of its cholesterol lowering drug Repatha…
Huge price hikes by drug companies are immoral
azfamily.com,
By Robert Klitzman Several pharmaceutical companies have been jacking up the prices of their drugs in unethical ways.
Huge price hikes by drug companies are immoral
CNN News,
Mulye argues that his only moral duty is to benefit his investors. As he said in defending Martin Shkreli, who in 2015 raised…
Huge price hikes by drug companies are immoral
Action News Now,
Several pharmaceutical companies have been jacking up the prices of their drugs in unethical ways.
Another View: Empower generics makers to sue when Big Pharma won’t play ball
Portland Press Herald,
Food and Drug Administration Commissioner Scott Gottlieb says he’s not looking to shame brand-name drug companies into…
News story from Bloomberg on Tuesday 22 May 2018
Bloomberg,
Trump offers a weak prescription on drug costs
Star Tribune,
In what he described Friday as “the most sweeping action in history to lower the price of prescription drugs for the American…
News story from Bloomberg on Saturday 12 May 2018
Bloomberg,
The Price They Pay
New York Times,
The New York Times and ProPublica, the independent, nonprofit investigative journalism organization, collaborated on this…
The Price They Pay
New York Times,
The New York Times and ProPublica, the independent, nonprofit investigative journalism organization, collaborated on this…
The Price They Pay
ProPublica,
The burden of high drug costs weighs most heavily on the sickest Americans. Drug makers have raised prices on treatments for…
Humira's best-selling drug formula: Start at high price
Business Standard,
Humira is the best-selling prescription drug in the world. You may have seen the commercials.
Humira’s Best-Selling Drug Formula: Start at a High Price. Go Higher.
New York Times,
“People are skipping doses, people are rationing, people are going into bankruptcy because of this drug,” he said in an…
Drugmakers are overcharging for lifesaving medications
The Seattle Times,
It is time for Washington state to stand up for the health of its citizens and demand drug companies lower prices and curb…
Now, can we try to fix the problem that could actually bring down the US healthcare system
Latest Nigerian News,
Published by Business Insider on Wed, 27 Sep 2017 American policymakers need to stop obsessing over Obamacare and tackle the…